Asymptomatic 60-year-old female with thrombocytopenia (platelet count 70 × 10⁹/L) – what is the initial blood workup?

Initial Blood Workup for Asymptomatic 60-Year-Old Female with Thrombocytopenia (70,000)

In an asymptomatic 60-year-old woman with a platelet count of 70,000/μL, begin with a peripheral blood smear to confirm true thrombocytopenia and exclude pseudothrombocytopenia, followed by a complete blood count with differential, comprehensive metabolic panel, coagulation studies (PT/aPTT), and HIV/HCV testing. 1

Immediate First Steps

Confirm True Thrombocytopenia

• Repeat platelet count in a sodium citrate or heparin tube to exclude pseudothrombocytopenia (occurs in ~0.1% of adults due to EDTA-dependent platelet clumping) 2, 3
• Direct examination of peripheral blood smear is mandatory to confirm the diagnosis and assess platelet morphology 2, 1

Essential Initial Laboratory Panel

The 2010 International Consensus Report provides clear guidance on basic evaluation 1:

Core Tests:

• Complete blood count with reticulocyte count
• Peripheral blood film examination (assess for schistocytes, platelet size/morphology, other cell line abnormalities)
• Comprehensive metabolic panel (liver and kidney function)
• Coagulation profile: PT/aPTT, fibrinogen
• Direct antiglobulin test (Coombs test)
• HIV testing
• Hepatitis C virus testing
• Quantitative immunoglobulin levels

Critical Point for Age 60: Elderly patients with thrombocytopenia have atypical presentations more frequently, and conditions like TTP may present with less profound thrombocytopenia but more severe organ involvement 4. The platelet count of 70,000/μL is actually higher than typical for TTP (usually <30,000/μL), but this does not exclude serious conditions in this age group 4.

Risk Stratification Based on Blood Smear Findings

If Schistocytes Present on Smear:

This suggests thrombotic microangiopathy (TMA) and requires urgent additional workup 4:

• ADAMTS13 activity level (send before any plasma therapy)
• LDH and indirect bilirubin (hemolysis markers)
• Haptoglobin
• Direct antiglobulin test
• Creatinine and urinalysis (proteinuria, hematuria)
• Troponin (cardiac involvement more common in elderly)
• Pregnancy test (if applicable)

Caveat: Schistocytes may be initially absent even in TMA, so their absence does not rule out serious conditions 4.

If No Schistocytes:

Proceed with evaluation for primary immune thrombocytopenia (ITP) or secondary causes 1:

Additional Tests of Potential Utility:

• Antinuclear antibodies (ANA)
• Antiphospholipid antibodies (anticardiolipin, lupus anticoagulant)
• Thyroid function tests and antithyroid antibodies
• Helicobacter pylori testing (associated with ITP)

Tests NOT Recommended:

• Platelet-associated IgG (lacks specificity) 2, 1
• Platelet survival studies 2
• Bleeding time 1
• Serum complement levels 2

When to Consider Bone Marrow Examination

Bone marrow examination is not routinely required for diagnosis of ITP but should be considered in 1:

• Age >60 years (higher risk of myelodysplastic syndrome)
• Abnormalities in other cell lines
• Atypical features on peripheral smear
• Before splenectomy
• Failure to respond to initial therapy

Medication History is Critical

Specifically inquire about:

• Heparin exposure (HIT can occur in up to 1% with unfractionated heparin) 5
• Quinidine/quinine
• Sulfonamides and sulfonylureas
• Antiplatelet agents (aspirin, dipyridamole)
• Alcohol use 2
• Recent vaccinations (VITT typically 5-30 days post-vaccination) 6

Physical Examination Priorities

Focus on findings that suggest alternative diagnoses 2, 1:

• Splenomegaly (present in <3% of ITP; suggests lymphoproliferative disorder, liver disease, or splenic sequestration)
• Lymphadenopathy (lymphoproliferative disorder)
• Stigmata of chronic liver disease
• Neurologic abnormalities (TTP, though less common with platelet count of 70,000)
• Signs of infection or autoimmune disease
• Skeletal anomalies or hearing impairment (congenital thrombocytopenia syndromes) 7

Bleeding Assessment

At a platelet count of 70,000/μL, spontaneous bleeding is rare 2, 8. However, assess for:

• Type and severity of any bleeding symptoms
• Petechiae, purpura, ecchymosis
• Mucosal bleeding
• Menorrhagia
• Prior hemostasis with surgeries or procedures

Patients with counts >50,000/μL are generally asymptomatic 3, 9.

Common Pitfalls to Avoid

1. Don't assume ITP without excluding secondary causes - HIV, HCV, medications, and autoimmune disorders must be ruled out 1

2. Don't miss pseudothrombocytopenia - Always confirm with blood smear and repeat count in different anticoagulant 2, 3

3. Don't overlook age-specific risks - At age 60, consider myelodysplastic syndrome and increased risk of medication-induced thrombocytopenia 1, 5

4. Don't delay ADAMTS13 testing if any concern for TMA - Must be drawn before plasma therapy if TTP is suspected 4

5. Don't order platelet antibody testing - Platelet-associated IgG is neither sensitive nor specific and is considered inappropriate 2, 1